BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development

According to the collaboration agreements, WuXi XDC will actively promote GeneQuantum’s proprietary iLDC (intelligent Ligase-dependent Conjugation) a...

December 28, 2022 | News

Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership

“We are excited about the strategic manufacturing partnership with Richter-Helm BioLogics. As a leading manufacturer of DNA vaccines, they will provi...

December 20, 2022 | News

Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19

Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data in American, Japanese and Chinese patients, 800 mg twice daily of ASC...

December 13, 2022 | News

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an international pharmaceutical co...

December 09, 2022 | News

Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China

Thermo Fisher Scientific, the world leader in serving science, is opening a new facility in Hangzhou, China, as part of its global effort to help comp...

December 08, 2022 | News

Fraunhofer IZI Selects Lonza’s MOD A-ES® Solution to Digitalize Manufacturing Operations

The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (M...

December 06, 2022 | News

WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi city site

This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...

December 01, 2022 | News

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...

November 28, 2022 | News

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation...

November 23, 2022 | News

Merck to Acquire Imago BioSciences, Inc.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announce...

November 22, 2022 | News

GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments

S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more q...

November 21, 2022 | News

Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the Investigational New Drug (IND) application by China National Medical Prod...

November 17, 2022 | News

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

First mRNA manufacturing facility in Singapore will create regional manufacturing capacities in support of BioNTech’s growing pipeline of...

November 14, 2022 | News

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Selinexor was granted orphan drug designation in MF by the U. S. Food and Drug Administration (FDA) in May 2022. Karyopharm is currently evaluating se...

November 02, 2022 | News

Stay Connected